Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Foghorn Therapeutics Stock Price, Quotes and Forecasts | NASDAQ:FHTX | Benzinga

Q: What sector and industry does Foghorn Therapeutics (FHTX) operate in?

Foghorn Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Explore Foghorn Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for FHTX.

Open	$3.55
Close	-
Volume / Avg.	5.71K / 134.38K
Day Range	$3.41 - $3.56
52 Wk Range	2.94 - 10.25
Market Cap	$197.98M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	45
Short Interest	2.81%
Days to Cover	7.45

Recent News

Why PVH Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket

Avi Kapoor

This Worthington Enterprises Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday

Avi Kapoor

Why Foghorn Therapeutics (FHTX) Stock Is Trading Lower

Foghorn Therapeutics shares are trading lower by 20.2% during Monday's session. The company announced it will discontinue independent development of its FHD-286 program.

Henry Khederian

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Dec 24

Jan

Mar

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.8

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$3.55
Close	-
Volume / Avg.	5.71K / 134.38K
Day Range	$3.41 - $3.56
52 Wk Range	2.94 - 10.25
Market Cap	$197.98M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	45
Short Interest	2.81%
Days to Cover	7.45

About Foghorn Therapeutics Inc

Sector

Health Care

Industry

Biotechnology

Foghorn Therapeutics Inc is engaged in the discovery and development of a new class of medicines tar...

Got Questions? Ask

Analyze FHTX's financials

What is FHTX's 5 years max drawdown?

What is FHTX's drawdown from recent high?

What is FHTX's gross margin?

What is FHTX's P/S ratio?

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Foghorn Therapeutics (FHTX) stock?

You can purchase shares of Foghorn Therapeutics (NASDAQ:FHTX) through any online brokerage.

View our list of the best stock brokerages

Who are Foghorn Therapeutics (FHTX) competitors?

Other companies in Foghorn Therapeutics’s space includes: Voyager Therapeutics (NASDAQ:VYGR), Tevogen Bio Holdings (NASDAQ:TVGN), Anika Therapeutics (NASDAQ:ANIK), Eledon Pharmaceuticals (NASDAQ:ELDN) and Genfit (NASDAQ:GNFT).

What is the forecast, or price target, for Foghorn Therapeutics (FHTX) stock?

Foghorn Therapeutics has a consensus price target of $14.11.

What is the current price for Foghorn Therapeutics (FHTX)?

The stock price for Foghorn Therapeutics (NASDAQ: FHTX) is $3.56 last updated April 16, 2025 at 11:00 AM EDT.

Does Foghorn Therapeutics (FHTX) pay a dividend?

There are no upcoming dividends for Foghorn Therapeutics.

When is Foghorn Therapeutics (NASDAQ:FHTX) reporting earnings?

Foghorn Therapeutics’s Q1 earnings are confirmed for Monday, May 5, 2025.

Is Foghorn Therapeutics (FHTX) going to split?

There is no upcoming split for Foghorn Therapeutics.

What sector and industry does Foghorn Therapeutics (FHTX) operate in?

Foghorn Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Comments

Foghorn Therapeutics Stock Price, Quotes and Forecasts

Foghorn Therapeutics (FHTX) Forecast